Hormone levels and response to isotretinoin for acne in women
Part of Skin clinical trials.
This study looks at how a woman's natural hormone levels affect how well she responds to isotretinoin (a strong acne pill). It aims to help doctors predict which patients will benefit most from this treatment.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be a woman aged 18 or older.
- You must have moderate to severe acne.
- You must be planning to start treatment with isotretinoin (a strong oral acne medication).
- You must not have used hormonal treatments (like birth control pills, anti-androgens, or steroid medications) in the last 3 months.
- You must not have any medical conditions that make isotretinoin unsafe for you.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study compares two doses of an acne pill called isotretinoin to see if a lower dose works as well as the standard dose with fewer side effects. If you have moderate to severe acne, this trial might help you find an effective treatment with less risk of side effects.
This study looks at how the bacteria on your face change when you take a medicine called isotretinoin for acne. It might help doctors understand why the medicine works and how to improve acne treatment.
This trial compares oral isotretinoin (a strong acne medication) to standard treatments for people with moderate acne and darker skin tones. It aims to find which treatment works best for skin of color.
This trial tests a weekly dose of isotretinoin (a strong acne medicine) versus a standard tetracycline antibiotic for treating moderate acne. It aims to find a simpler, effective option with fewer side effects.
This trial tests a new combination hormonal pill (a progestogen and low-dose estrogen) to treat moderate acne in women. It may be an option if you have not had success with other acne treatments.
This trial measures a blood protein called catestatin in people with moderate to severe acne. It aims to understand how catestatin relates to acne, which may help guide future treatments.
Hear when a new Acne Vulgaris trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.